$IKNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ikena Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ikena Oncology, Inc.. Get notifications about new insider transactions in Ikena Oncology, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | IKNA | Ikena Oncology, In ... | Koehler Maria | Director | Option Exercise | A | 18.45 | 26,838 | 495,161 | 26,838 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 5,362,888 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 7,863,094 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 11,258,117 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | C | 0.00 | 9,499,999 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Option Exercise | A | 0.00 | 5,362,888 | 0 | 5,362,888 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Buy | C | 0.00 | 749,634 | 0 | 749,634 | 0 to 749.6 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Buy | C | 0.00 | 1,099,118 | 0 | 1,268,213 | 169.1 K to 1.3 M (+650.00 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | FORMELA JEAN FRANCOIS | Director | Buy | C | 0.00 | 2,901,609 | 0 | 2,901,609 | 0 to 2.9 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Stampacchia Otello | Director | Option Exercise | C | 0.00 | 12,870,933 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Stampacchia Otello | Director | Option Exercise | A | 0.00 | 12,870,933 | 0 | 12,870,933 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Stampacchia Otello | Director | Grant | A | 16.00 | 450,000 | 7,200,000 | 2,249,123 | 1.8 M to 2.2 M (+25.01 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Stampacchia Otello | Director | Buy | C | 0.00 | 1,799,123 | 0 | 1,799,123 | 0 to 1.8 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,362,888 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,863,094 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,258,117 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,499,999 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 749,634 | 0 | 749,634 | 0 to 749.6 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 1,099,118 | 0 | 1,268,213 | 169.1 K to 1.3 M (+650.00 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 2,901,609 | 0 | 2,901,609 | 0 to 2.9 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 130,924 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 328,907 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 920,484 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 806,752 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,257,785 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 680,766 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 1,905,201 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 1,430,103 | 0 | 1,430,103 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 8,938,148 | 0 | 8,938,148 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 130,924 | 0 | 130,924 | 0 to 130.9 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 5,083,470 | 0 | 5,083,470 | 0 to 5.1 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 48,400 | 774,400 | 117,378 | 69 K to 117.4 K (+70.17 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,191,425 | 1.8 M to 2.2 M (+20.64 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 68,978 | 0 | 68,978 | 0 to 69 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 1,816,425 | 0 | 1,816,425 | 0 to 1.8 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 130,924 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 328,907 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 920,484 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 806,752 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,257,785 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 680,766 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,905,201 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.00 | 1,430,103 | 0 | 1,430,103 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.00 | 8,938,148 | 0 | 8,938,148 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 130,924 | 0 | 130,924 | 0 to 130.9 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 5,083,470 | 0 | 5,083,470 | 0 to 5.1 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 48,400 | 774,400 | 117,378 | 69 K to 117.4 K (+70.17 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,191,425 | 1.8 M to 2.2 M (+20.64 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 68,978 | 0 | 68,978 | 0 to 69 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,816,425 | 0 | 1,816,425 | 0 to 1.8 M |
Page: 1